Short-Term Active Safety Surveillance of the Spikevax and Nuvaxovid Priming Doses in Australia.

MLA

Reynolds, Renee, et al. “Short-Term Active Safety Surveillance of the Spikevax and Nuvaxovid Priming Doses in Australia.” Vaccines, vol. 12, no. 9, Sept. 2024, p. 971. EBSCOhost, https://doi.org/10.3390/vaccines12090971.

APA

Reynolds, R., Tay, E., Dymock, M., Deng, L., Glover, C., Lopez, L. K., Huang, Y. A., Cashman, P., Leeb, A., Marsh, J. A., Snelling, T., Wood, N., & Macartney, K. (2024). Short-Term Active Safety Surveillance of the Spikevax and Nuvaxovid Priming Doses in Australia. Vaccines, 12(9), 971. https://doi.org/10.3390/vaccines12090971

Chicago

Reynolds, Renee, Evelyn Tay, Michael Dymock, Lucy Deng, Catherine Glover, Laura K. Lopez, Yuanfei Anny Huang, et al. 2024. “Short-Term Active Safety Surveillance of the Spikevax and Nuvaxovid Priming Doses in Australia.” Vaccines 12 (9): 971. doi:10.3390/vaccines12090971.